196 related articles for article (PubMed ID: 35641026)
1. SARS-CoV-2 induces barrier damage and inflammatory responses in the human iPSC-derived intestinal epithelium.
Yamada S; Noda T; Okabe K; Yanagida S; Nishida M; Kanda Y
J Pharmacol Sci; 2022 Jul; 149(3):139-146. PubMed ID: 35641026
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 causes dysfunction in human iPSC-derived brain microvascular endothelial cells potentially by modulating the Wnt signaling pathway.
Yamada S; Hashita T; Yanagida S; Sato H; Yasuhiko Y; Okabe K; Noda T; Nishida M; Matsunaga T; Kanda Y
Fluids Barriers CNS; 2024 Apr; 21(1):32. PubMed ID: 38584257
[TBL] [Abstract][Full Text] [Related]
3. Human airway lineages derived from pluripotent stem cells reveal the epithelial responses to SARS-CoV-2 infection.
Wang R; Hume AJ; Beermann ML; Simone-Roach C; Lindstrom-Vautrin J; Le Suer J; Huang J; Olejnik J; Villacorta-Martin C; Bullitt E; Hinds A; Ghaedi M; Rollins S; Werder RB; Abo KM; Wilson AA; Mühlberger E; Kotton DN; Hawkins FJ
Am J Physiol Lung Cell Mol Physiol; 2022 Mar; 322(3):L462-L478. PubMed ID: 35020534
[TBL] [Abstract][Full Text] [Related]
4. Human Pluripotent Stem Cell-Derived Intestinal Organoids Model SARS-CoV-2 Infection Revealing a Common Epithelial Inflammatory Response.
Mithal A; Hume AJ; Lindstrom-Vautrin J; Villacorta-Martin C; Olejnik J; Bullitt E; Hinds A; Mühlberger E; Mostoslavsky G
Stem Cell Reports; 2021 Apr; 16(4):940-953. PubMed ID: 33852884
[TBL] [Abstract][Full Text] [Related]
5. Effective SARS-CoV-2 replication of monolayers of intestinal epithelial cells differentiated from human induced pluripotent stem cells.
Minami S; Matsumoto N; Omori H; Nakamura Y; Tamiya S; Nouda R; Nurdin JA; Yamasaki M; Kotaki T; Kanai Y; Okamoto T; Tachibana T; Ushijima H; Kobayashi T; Sato S
Sci Rep; 2023 Jul; 13(1):11610. PubMed ID: 37463955
[TBL] [Abstract][Full Text] [Related]
6. Chronic alcohol use primes bronchial cells for altered inflammatory response and barrier dysfunction during SARS-CoV-2 infection.
Easley KF; Edenfield RC; Lott MEJ; Reed RC; Das Sarma J; Mehta AJ; Staitieh BS; Lipp EK; Cho IK; Johnson SK; Jones CA; Bebin-Blackwell AG; Levy JM; Tompkins SM; Easley CA; Koval M
Am J Physiol Lung Cell Mol Physiol; 2023 Nov; 325(5):L647-L661. PubMed ID: 37786945
[TBL] [Abstract][Full Text] [Related]
7. Generation of Angiotensin-Converting Enzyme 2/Transmembrane Protease Serine 2-Double-Positive Human Induced Pluripotent Stem Cell-Derived Spheroids for Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Drug Evaluation.
Higashi-Kuwata N; Yabe SG; Fukuda S; Nishida J; Tamura-Nakano M; Hattori SI; Okochi H; Mitsuya H
Microbiol Spectr; 2022 Dec; 10(6):e0349022. PubMed ID: 36314907
[TBL] [Abstract][Full Text] [Related]
8. Replication Kinetics, Cell Tropism, and Associated Immune Responses in SARS-CoV-2- and H5N1 Virus-Infected Human Induced Pluripotent Stem Cell-Derived Neural Models.
Bauer L; Lendemeijer B; Leijten L; Embregts CWE; Rockx B; Kushner SA; de Vrij FMS; van Riel D
mSphere; 2021 Jun; 6(3):e0027021. PubMed ID: 34160239
[TBL] [Abstract][Full Text] [Related]
9. Micro-patterned culture of iPSC-derived alveolar and airway cells distinguishes SARS-CoV-2 variants.
Masui A; Hashimoto R; Matsumura Y; Yamamoto T; Nagao M; Noda T; Takayama K; Gotoh S
Stem Cell Reports; 2024 Apr; 19(4):545-561. PubMed ID: 38552631
[TBL] [Abstract][Full Text] [Related]
10. Innate immune response to SARS-CoV-2 infection contributes to neuronal damage in human iPSC-derived peripheral neurons.
Passos V; Henkel LM; Wang J; Zapatero-Belinchón FJ; Möller R; Sun G; Waltl I; Schneider T; Wachs A; Ritter B; Kropp KA; Zhu S; Deleidi M; Kalinke U; Schulz TF; Höglinger G; Gerold G; Wegner F; Viejo-Borbolla A
J Med Virol; 2024 Feb; 96(2):e29455. PubMed ID: 38323709
[TBL] [Abstract][Full Text] [Related]
11. Induced pluripotent stem cell-based disease modeling and prospective immune therapy for coronavirus disease 2019.
Chakrabarty K; Shetty R; Argulwar S; Das D; Ghosh A
Cytotherapy; 2022 Mar; 24(3):235-248. PubMed ID: 34656419
[TBL] [Abstract][Full Text] [Related]
12. Development of alveolar and airway cells from human iPS cells: toward SARS-CoV-2 research and drug toxicity testing.
Tsuji K; Yamada S; Hirai K; Asakura H; Kanda Y
J Toxicol Sci; 2021; 46(9):425-435. PubMed ID: 34470994
[TBL] [Abstract][Full Text] [Related]
13. Differential immune activation profile of SARS-CoV-2 and SARS-CoV infection in human lung and intestinal cells: Implications for treatment with IFN-β and IFN inducer.
Shuai H; Chu H; Hou Y; Yang D; Wang Y; Hu B; Huang X; Zhang X; Chai Y; Cai JP; Chan JF; Yuen KY
J Infect; 2020 Oct; 81(4):e1-e10. PubMed ID: 32707230
[TBL] [Abstract][Full Text] [Related]
14. iPSC-derived mesenchymal cells that support alveolar organoid development.
Tamai K; Sakai K; Yamaki H; Moriguchi K; Igura K; Maehana S; Suezawa T; Takehara K; Hagiwara M; Hirai T; Gotoh S
Cell Rep Methods; 2022 Oct; 2(10):100314. PubMed ID: 36313800
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 infection of polarized human airway epithelium induces necroptosis that causes airway epithelial barrier dysfunction.
Hao S; Ning K; Kuz CA; Xiong M; Zou W; Park SY; McFarlin S; Yan Z; Qiu J
J Med Virol; 2023 Sep; 95(9):e29076. PubMed ID: 37671751
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 infection of human-induced pluripotent stem cells-derived lung lineage cells evokes inflammatory and chemosensory responses by targeting mitochondrial pathways.
Surendran H; Kumar S; Narasimhaiah S; Ananthamurthy A; Varghese PS; D'Souza GA; Medigeshi G; Pal R
J Cell Physiol; 2022 Jul; 237(7):2913-2928. PubMed ID: 35460571
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of gastrointestinal barrier dysfunction in COVID-19 patients.
Xue W; Honda M; Hibi T
World J Gastroenterol; 2023 Apr; 29(15):2283-2293. PubMed ID: 37124884
[TBL] [Abstract][Full Text] [Related]
18. Human iPSC-Derived Cardiomyocytes Are Susceptible to SARS-CoV-2 Infection.
Sharma A; Garcia G; Wang Y; Plummer JT; Morizono K; Arumugaswami V; Svendsen CN
Cell Rep Med; 2020 Jul; 1(4):100052. PubMed ID: 32835305
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 infection of human iPSC-derived cardiac cells reflects cytopathic features in hearts of patients with COVID-19.
Perez-Bermejo JA; Kang S; Rockwood SJ; Simoneau CR; Joy DA; Silva AC; Ramadoss GN; Flanigan WR; Fozouni P; Li H; Chen PY; Nakamura K; Whitman JD; Hanson PJ; McManus BM; Ott M; Conklin BR; McDevitt TC
Sci Transl Med; 2021 Apr; 13(590):. PubMed ID: 33723017
[TBL] [Abstract][Full Text] [Related]
20. Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.
Vanderheiden A; Ralfs P; Chirkova T; Upadhyay AA; Zimmerman MG; Bedoya S; Aoued H; Tharp GM; Pellegrini KL; Manfredi C; Sorscher E; Mainou B; Lobby JL; Kohlmeier JE; Lowen AC; Shi PY; Menachery VD; Anderson LJ; Grakoui A; Bosinger SE; Suthar MS
J Virol; 2020 Sep; 94(19):. PubMed ID: 32699094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
